Xtalks Webinars

Which pharma companies are shaping the next phase of biopharma? Fast Company’s 2026 list spotlights innovators across HIV prevention, non-opioid pain, RNAi, vaccines, cancer and women’s health. See Xtalks’ breakdown of the top 10 most innovative pharma companies of 2026: buff.ly/zj1ChpY #Pharma #Biopharma #LifeSciences #DrugDevelopment #PharmaInnovation

Transform healthy aging beyond conventional collagen with Daniel Martínez-Puig in this webinar hosted by STAUBER. As longevity science advances, beauty-first supplementation is giving way to systems-based strategies for skin structure, mobility, muscle health, and long-term vitality. Explore how next-generation bioactive compounds and peptides may help address the evolving demands of healthspan innovation. Register for this webinar to learn how traditional collagen limitations, novel peptides, and whole-body longevity strategies are reshaping science-driven wellness: xtalks.com/webinars/the-f… #Stauber #LongevityScience #HealthyAging #Healthspan #BioactivePeptides #CollagenScience #SkinHealth #MobilityHealth #MuscleHealth #Nutraceuticals #WellnessInnovation #LifeSciences #Biopharma #IngredientInnovation

Transform obesity trial design for durable patient and payer value with Leslie Harrold, MD, MPH, Hayley Karn, PhD, CPsychol, Almudena Olid Gonzalez, MA, Firas M. Dabbous, PhD, MS, Eling Gaines and Todd Rudo, MD in this webinar hosted by The PPD clinical research business of Thermo Fisher Scientific Inc.. Weight loss alone no longer defines obesity therapy success. Sponsors must generate integrated evidence that demonstrates metabolic, cardiovascular, functional and quality-of-life value across real-world populations, while supporting reimbursement and long-term access. Register for this webinar to learn how to design patient-centric trials, integrate real-world evidence and build payer-relevant strategies for durable differentiation: xtalks.com/webinars/beyon… #ThermoFisherScientific #ObesityResearch #ObesityTrials #ClinicalTrials #RealWorldEvidence #PatientCenteredResearch #MarketAccess #HealthEconomics #HEOR #CardiovascularHealth #MetabolicHealth #ClinicalDevelopment #Biopharma #LifeSciences

Pharma and biotech layoffs are continuing in 2026, as companies from Takeda and Merck to enGene and Fulcrum cut roles, reduce costs and refocus pipelines. Read the latest roundup on what’s changing across the sector: buff.ly/QJxzmJR #Pharma #Biotech #PharmaLayoffs #LifeSciences #BiotechNews

Transform complex oncology innovation into executable trial strategy with (Moderator) Dannelle Palmer, MBA, Scott Schliebner, Dr. Julio A. Peguero and Dr. Brandon Fletcher in this webinar hosted by Humaneva Group. ASCO 2026 signals a new era where precision medicine, immune-based therapies, biomarkers and AI are converging, while trial execution grows more complex. Translating breakthrough data into feasible protocols, patient access and high-quality evidence requires tighter alignment across sponsors, CROs, sites and investigators. Register for this webinar to learn how ASCO 2026 data can sharpen protocol design, patient selection and operational readiness for complex oncology trials: xtalks.com/webinars/asco-… #HumanevaGroup #ASCO2026 #Oncology #ClinicalTrials #OncologyResearch #PrecisionMedicine #Immunotherapy #Biomarkers #PersonalizedMedicine #CancerVaccines #BispecificAntibodies #ClinicalOperations #DrugDevelopment #PatientAccess #LifeSciences

Patients are looking for people who understand what it feels like to live with a diagnosis. Kristen Hartman from @InspireIsHealth dives into how online patient communities can support connection, treatment conversations and real-world insight across the patient journey. Read more in this exclusive Xtalks Spotlight interview at buff.ly/ZnxgnzE by @soumya2390. #PatientExperience #DigitalHealth #PatientSupport #HealthcareEngagement

Master cross-functional safety, labeling and crisis decisions with (Moderator) Alessandra Grossi, Elke Blaetz, RPh, MS, Ana Filipa Sousa and Dr. Kunvar Harsh Upveja in this webinar hosted by TransPerfect Life Sciences. As safety data grows more complex, seamless collaboration across Medical Information, Pharmacovigilance and Regulatory Affairs becomes essential to protect patients, support compliant communications and maintain labeling consistency. This session explores where critical handoffs succeed or fail, and how AI-enabled workflows can strengthen signal escalation, governance and coordinated response across the product lifecycle. Register for this webinar to learn how MI, PV and RA can improve signal escalation, labeling alignment and crisis response, while preparing for responsible AI adoption: xtalks.com/webinars/how-m… #TransPerfectLifeSciences #LifeSciences #Biopharma #Pharmacovigilance #RegulatoryAffairs #MedicalInformation #DrugSafety #PatientSafety #LabelingCompliance #MedicalAffairs #ArtificialIntelligence #PharmaOperations #CrisisManagement #SignalDetection

What will it take to improve pulmonary hypertension care in Canada? @PHACanada’s Jamie Myrah shares how the organization is addressing diagnosis delays, expanding support, investing in registries and helping ensure patients are engaged earlier in PH research. Read the full interview: buff.ly/vJs3PdB #PulmonaryHypertension #PHACanada #PAH #CTEPH #RareDisease #PatientOrientedResearch #HealthcareAccess

Transform fragmented pharma intelligence into decisive action with Dr. Sanika Bhide and Stephen Shewbrooks in this webinar hosted by Anervea.AI. When every function builds its own CI model, organizations end up with duplicated effort, conflicting interpretations, and slower commercial decisions. This session explores how AI is reshaping competitive intelligence from passive monitoring into an enterprise decision engine built on shared data, field intelligence, and function-specific workflows. Register for this webinar to learn how to move from disconnected monitoring to decision-ready CI, and build a shared intelligence foundation that delivers the right insight to the right team at the right time: buff.ly/sEHhuYW #AnerveaAI #PharmaCI #CompetitiveIntelligence #Biopharma #LifeSciences #ArtificialIntelligence #CommercialStrategy #MarketIntelligence #PharmaAnalytics #DecisionIntelligence #PharmaCommercial #EnterpriseAI #DrugDevelopment #BiotechStrategy

Overcome downstream bottlenecks in chromatography operations with Jason Corbiere in this webinar hosted by Astrea Bioseparations. As upstream titers rise and process complexity increases, traditional column packing can strain timelines, labor capacity, and cost control. Discover how pre-packed and outsourced column strategies can improve campaign readiness, reduce variability, and unlock greater manufacturing agility across scales. Register for this webinar to learn how to improve operational flexibility, protect resin performance, and reduce internal burden with smarter packing strategies: xtalks.com/webinars/reduc… #AstreaBioseparations #Bioprocessing #DownstreamProcessing #Chromatography #PrePackedColumns #Biomanufacturing #ProcessDevelopment #Biopharma #LifeSciences #ResinRecovery #ManufacturingAgility #CostOfGoods #GMP #Biotech

We have updated our Pharma and Biotech M&As 2026 Deal Watcher with new transactions across rare disease, immunology, lung cancer, lab tools, oncology and infectious disease, including major moves from Vertex, AbbVie, GSK and Merck KGaA. Read the latest update: buff.ly/RpkNk0u #Pharma #Biotech #M&A #LifeSciences #DrugDevelopment

🔬 The life sciences workforce is changing as AI, digital technologies, and scientific innovation reshape the industry. Which skill will be most important for life sciences professionals over the next 5 years? buff.ly/PHj5HEb 🗳️ Vote in our poll and share your thoughts in the comments: #LifeSciences #FutureOfWork #Pharma #Biotech

We have updated our Pharma and Biotech M&As 2026 Deal Watcher with new transactions across rare disease, immunology, lung cancer, lab tools, oncology and infectious disease, including major moves from Vertex, AbbVie, GSK and Merck KGaA. Read the latest update: buff.ly/RpkNk0u #Pharma #Biotech #M&A #LifeSciences #DrugDevelopment

Just updated our Biotech IPOs of 2026 blog with new entries on companies advancing precision cardiology and platform-driven cancer drug discovery. Head on over for the latest additions: buff.ly/G5MA9G1 #BiotechIPO #BiotechNews #DrugDevelopment #PrecisionMedicine #LifeSciences

Master hidden bispecific developability risks with Ammar Arsiwala in this webinar hosted by Ginkgo Datapoints. As bispecific pipelines expand, early developability assumptions can obscure pairing risk, inherited liabilities, and assembly-driven failure modes. This session examines how systematic parental profiling and large-scale bsAb dataset design can sharpen prediction, expose where additivity breaks down, and support earlier de-risking of complex biologics. Register for this webinar to learn how developability data can predict bsAb pairing risk, reveal emergent liabilities, and improve parental screening decisions earlier in development: xtalks.com/webinars/predi… #GinkgoDatapoints #BispecificAntibodies #BsAb #AntibodyDevelopability #BiologicsDevelopment #TherapeuticAntibodies #DrugDiscovery #Biopharma #LifeSciences #ProteinEngineering #CMCStrategy #TranslationalScience #Biotherapeutics

Master multi-site assay concordance challenges with Lynn Kamen, PhD, Jessica Weaver, Pavan Prathipati, PhD, Bryan M. Gullick, PhD, Michael Mullen and Todd Lester in this webinar hosted by BioAgilytix. As global drug development expands, cross-validating bioanalytical assays across laboratory sites has become a critical requirement for data integrity and regulatory readiness. Misalignment in protocols, reagents, instrumentation, or interpretation can introduce variability that weakens comparability and increases downstream clinical and submission risk. Register for this webinar to learn how to strengthen assay transfer, demonstrate inter-site concordance, and apply fit-for-purpose statistical approaches to reduce risk in multi-site programs: xtalks.com/webinars/strat… #BioAgilytix #LifeSciences #Biopharma #Bioanalysis #BioanalyticalAssays #AssayValidation #CrossValidation #ClinicalTrials #DrugDevelopment #Biomarkers #Immunogenicity #Pharmacokinetics #RegulatoryScience #TranslationalScience

Xtalks Social Media Post: July is Fibroids Awareness Month. Uterine fibroids are common, but their impact can be deeply personal, affecting bleeding, pain, fertility, pregnancy and quality of life. Here’s what to know about symptoms, care decisions and recent treatment updates at: buff.ly/TyX90iY #FibroidsAwarenessMonth #UterineFibroids #WomensHealth #ReproductiveHealth #MedTech

A new biotech has joined the public markets in 2026, this time with a pipeline focused on ulcerative colitis, lupus and autoimmune disease. See the latest update in our Pharma and Biotech IPOs of 2026 blog: buff.ly/G5MA9G1 #Biotech #Pharma #IPO #Immunology #DrugDevelopment

We have updated our Pharma and Biotech M&As 2026 Deal Watcher with new transactions across rare disease, immunology, lung cancer, lab tools, oncology and infectious disease, including major moves from Vertex, AbbVie, GSK and Merck KGaA. Read the latest update at {URL} by @soumya2390. #Pharma #Biotech #M&A #LifeSciences #DrugDevelopment

Master the gap between data access and credible evidence with Jeffrey S. Brown, PhD and Miguel Hernán, MD, PhD, ScD in this webinar hosted by TriNetX. As real-world data becomes central to evidence generation, the real challenge is not volume, it is aligning the research question, study design, and data source with rigor. This session explores a practical framework for causal inference, helping teams avoid fit-for-purpose missteps and make more transparent, decision-ready RWD choices. Register for this webinar to learn how to sequence question, design, and data selection, and assess dataset fitness-for-purpose with actionable decision points: xtalks.com/webinars/from-… #TriNetX #LifeSciences #Biopharma #RealWorldData #RealWorldEvidence #CausalInference #StudyDesign #TargetTrial #Epidemiology #Pharmacoepidemiology #HealthOutcomes #ClinicalResearch #EvidenceGeneration #DataScience